2.1.11. Imetelstat - Orphan - EMEA-001910-PIP03-20
Geron Corporation; Treatment of Acute Myeloid Leukemia (AML), Treatment of Myelodysplastic Syndromes (MDS), including Juvenile Myelomonocytic Leukemia (JMML) / Treatment of pediatric patients with relapsed or refractory AML or MDS, including JMML, from 28 days to less than 18 years of age
Day 120 opinion Action: For adoption Oncology
this took a while but more Orphan - obviously wasn't a rubber stamp
EMA - adopted orphan
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam